Gregorie Bupe, MD
Family Medicine · Tallahassee, FLNPI 1972952406
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Novo Nordisk at 26.4% of the total.
Across 31 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$154
- Pfizer$97
- AstraZeneca$73
- Novartis$57
- Phathom Pharmaceuticals, Inc.$33
- Merck$31
- plus $137 from 8 others
What the payments were for
- Food & beverage$583100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 8 | $154 |
| Pfizer | 6 | $97 |
| AstraZeneca(2 entities) | 3 | $73 |
| Novartis | 3 | $57 |
| Phathom Pharmaceuticals, Inc. | 1 | $33 |
| Merck | 2 | $31 |
| Mylan Specialty L.p. | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| KARL Storz Endoscopy-america | 1 | $18 |
| Smith+Nephew | 1 | $17 |
| Cvrx, Inc. | 1 | $16 |
| Shionogi Inc | 1 | $15 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $14 |
| Amgen | 1 | $13 |
How this compares
$583 in reported general payments places this provider in the 55th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 55 | $637 |
| Fluticasone Propionate | 24 | $355 |
| Omeprazole | 13 | $349 |
| Levothyroxine Sodium | 18 | $320 |
| Metformin Hcl | 20 | $303 |
| Gabapentin | 13 | $275 |
| Pantoprazole Sodium | 22 | $271 |
| Trazodone Hcl | 12 | $263 |
| Lisinopril | 22 | $251 |
| Pregabalin | 12 | $158 |
| Losartan Potassium | 12 | $148 |
| Amlodipine Besylate | 22 | $143 |
| Clonazepam | 20 | $125 |
| Zolpidem Tartrate | 16 | $112 |
| Sertraline Hcl | 16 | $96 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Tallahassee
- Joseph MazziottaTallahassee$109K
- Hayley ScottTallahassee$84K
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.